Intestinal Kaposi sarcoma in a lung transplant recipient: therapy with mammalian target of rapamycin inhibitor and immunosuppression reduction

J Heart Lung Transplant. 2013 Mar;32(3):376-7. doi: 10.1016/j.healun.2012.11.031. Epub 2013 Jan 8.

Authors

May Brit Lund¹, Vemund Paulsen, Pål Aukrust

Affiliation

¹ Department of Respiratory Medicine, Oslo University Hospital, Norway.

PMID: 23305694
DOI: 10.1016/j.healun.2012.11.031

No abstract available

Publication types

Case Reports

MeSH terms

Everolimus
Female
Humans
Ileal Neoplasms / drug therapy*
Immunosuppression Therapy
Immunosuppressive Agents / administration & dosage*
Jejunal Neoplasms / drug therapy*
Lung Transplantation*
Middle Aged
Sarcoma, Kaposi / drug therapy*
Sirolimus / analogs & derivatives*
Sirolimus / therapeutic use
TOR Serine-Threonine Kinases / antagonists & inhibitors*

Substances

Immunosuppressive Agents
Everolimus
MTOR protein, human
TOR Serine-Threonine Kinases
Sirolimus